View in EDS HTML Full Text PDF Full Text

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs.

Saved in:
Bibliographic Details
Title: The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs.
Authors: Murai, Kazuhiro1 (AUTHOR), Hikita, Hayato1 (AUTHOR), Yamada, Ryoko1 (AUTHOR), Nishimura, Yuki2 (AUTHOR), Miyazaki, Masanori3 (AUTHOR), Ishida, Hisashi4 (AUTHOR), Hosui, Atsushi5 (AUTHOR), Sakamori, Ryotaro6 (AUTHOR), Tatsumi, Nobuyuki7 (AUTHOR), Ohkawa, Kazuyoshi8 (AUTHOR), Doi, Yoshinori9 (AUTHOR), Nawa, Takatoshi10 (AUTHOR), Egawa, Satoshi11 (AUTHOR), Yoshida, Yuichi12 (AUTHOR), Nozaki, Yasutoshi13 (AUTHOR), Imanaka, Kazuho14 (AUTHOR), Nakahara, Masanori15 (AUTHOR), Sakakibara, Mitsuru16 (AUTHOR), Yakushijin, Takayuki17 (AUTHOR), Ogawa, Hiroyuki18 (AUTHOR)
Source: Hepatology Research. Sep2025, Vol. 55 Issue 9, p1228-1238. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13866346
DOI:10.1111/hepr.14225